Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Aziyo Biologics stock | $5.53

Learn how to easily invest in Aziyo Biologics stock.

Aziyo Biologics Inc
+ $0.22 ( + 3.98%)

Aziyo Biologics Inc is a medical devices business based in the US. Aziyo Biologics shares (AZYO) are listed on the NASDAQ and all prices are listed in US Dollars. Aziyo Biologics employs 175 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Aziyo Biologics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AZYO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Aziyo Biologics stock price (NASDAQ: AZYO)

Use our graph to track the performance of AZYO stocks over time.

Aziyo Biologics shares at a glance

Information last updated 2021-10-17.
Latest market close$5.53
52-week range$5.37 - $16.72
50-day moving average $7.52
200-day moving average $9.58
Wall St. target price$16.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.02

Buy Aziyo Biologics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Aziyo Biologics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aziyo Biologics price performance over time

Historical closes compared with the close of $5.53 from 2021-10-20

1 week (2021-10-14) 2.98%
1 month (2021-09-22) -26.46%
3 months (2021-07-22) -32.64%
6 months (2021-04-22) -55.65%
1 year (2020-10-21) -51.41%
2 years (2019-10-18) N/A
3 years (2018-10-18) N/A
5 years (2016-10-18) N/A

Aziyo Biologics financials

Revenue TTM $49.3 million
Gross profit TTM $20.6 million
Return on assets TTM -15.81%
Return on equity TTM -740.82%
Profit margin -39.65%
Book value $1.46
Market capitalisation $55.8 million

TTM: trailing 12 months

Shorting Aziyo Biologics shares

There are currently 2,190 Aziyo Biologics shares held short by investors – that's known as Aziyo Biologics's "short interest". This figure is 77.6% down from 9,793 last month.

There are a few different ways that this level of interest in shorting Aziyo Biologics shares can be evaluated.

Aziyo Biologics's "short interest ratio" (SIR)

Aziyo Biologics's "short interest ratio" (SIR) is the quantity of Aziyo Biologics shares currently shorted divided by the average quantity of Aziyo Biologics shares traded daily (recently around 24333.333333333). Aziyo Biologics's SIR currently stands at 0.09. In other words for every 100,000 Aziyo Biologics shares traded daily on the market, roughly 90 shares are currently held short.

To gain some more context, you can compare Aziyo Biologics's short interest ratio against those of similar companies.

However Aziyo Biologics's short interest can also be evaluated against the total number of Aziyo Biologics shares, or, against the total number of tradable Aziyo Biologics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aziyo Biologics's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Aziyo Biologics shares in existence, roughly 0 shares are currently held short) or 0.0014% of the tradable shares (for every 100,000 tradable Aziyo Biologics shares, roughly 1 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aziyo Biologics.

Find out more about how you can short Aziyo Biologics stock.

Aziyo Biologics share dividends

We're not expecting Aziyo Biologics to pay a dividend over the next 12 months.

Aziyo Biologics overview

Aziyo Biologics, Inc. , a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device; and cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. The company also provides FiberCel, ViBone, and OsterGro V that are designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. In addition, it offers contract manufacturing services for various products to corporate customers. The company sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. Aziyo Biologics, Inc.

Frequently asked questions

What percentage of Aziyo Biologics is owned by insiders or institutions?
Currently 8.754% of Aziyo Biologics shares are held by insiders and 93.28% by institutions.
How many people work for Aziyo Biologics?
Latest data suggests 175 work at Aziyo Biologics.
When does the fiscal year end for Aziyo Biologics?
Aziyo Biologics's fiscal year ends in December.
Where is Aziyo Biologics based?
Aziyo Biologics's address is: 12510 Prosperity Drive, Silver Spring, MD, United States, 20904
What is Aziyo Biologics's ISIN number?
Aziyo Biologics's international securities identification number is: US05479K1060

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site